Literature DB >> 3835550

Hepatomegaly and splenomegaly in Kawasaki disease.

G Ohshio, F Furukawa, H Fujiwara, Y Hamashima.   

Abstract

Pathologic studies of the liver were performed on 30 autopsied cases of Kawasaki disease. The cases were classified into four groups (stages I-IV), and stage IV was further divided into two subgroups according to the duration of the illness at the time of death. Liver weights were markedly increased in stage II (12-25 days) and in stage III (28-36 days) but returned to normal in stage IVb (7 months to 6 years). Likewise, spleen weights were also markedly increased in stages II and III. Stage I (0-9 days) and stage II were characterized by acute inflammation in portal area, and degree of inflammatory changes decreased gradually. There was significant correlation between hepatomegaly and the degree of inflammation in portal areas, but not with definite heart failure or the use of drugs. These data suggest that the pathogenesis of hepatomegaly in acute-stage Kawasaki disease involves the inflammation in portal areas and/or latent heart failure.

Entities:  

Mesh:

Year:  1985        PMID: 3835550     DOI: 10.3109/15513818509026899

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  7 in total

1.  Abnormal liver panel in acute kawasaki disease.

Authors:  Mohammed Eladawy; Samuel R Dominguez; Marsha S Anderson; Mary P Glodé
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

2.  Acute severe hepatitis with coagulopathy: An unusual presentation of Kawasaki syndrome in association with Epstein-Barr virus.

Authors:  M M Gordon; E D Silverman; J H Kim; A M Huber; K Furuya
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

3.  Positive hepatitis serologies with treatment for Kawasaki syndrome.

Authors:  S M Borowitz
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

4.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

5.  Kawasaki disease as a systemic vasculitis in childhood.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Nobuyuki Hiruta; Shiro Naoe
Journal:  Ann Vasc Dis       Date:  2010-12-02

6.  CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease.

Authors:  Yu Lun; Nozha Borjini; Noriko N Miura; Naohito Ohno; Nora G Singer; Feng Lin
Journal:  J Immunol       Date:  2021-06-07       Impact factor: 5.426

7.  Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens.

Authors:  J Q Russell; G J Morrissette; M Weidner; C Vyas; D Aleman-Hoey; R C Budd
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.